 | • レポートコード：D0GIR-09354 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、プロスタサイクリン薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。プロスタサイクリン薬の種類別市場規模（エポプロステノールナトリウム、トレプロスチニル、イロプロスト、ベラプロストナトリウム）、用途別市場規模（注射用、経口用、吸入用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：United Therapeutics、Teva、Actelion (J & J)、Bayer AG、GSK、Tide Pharma、Toray ・地域別グローバル市場分析 2015年-2020年 ・プロスタサイクリン薬の北米市場（アメリカ、カナダ、メキシコ） ・プロスタサイクリン薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・プロスタサイクリン薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・プロスタサイクリン薬の南米市場（ブラジル、アルゼンチン） ・プロスタサイクリン薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：エポプロステノールナトリウム、トレプロスチニル、イロプロスト、ベラプロストナトリウム ・用途別分析：注射用、経口用、吸入用 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Prostacyclin Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Prostacyclin Drug sales will be xx in 2020 from Prostacyclin Drug million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Prostacyclin Drug market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Prostacyclin Drug industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Prostacyclin Drug and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Prostacyclin Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prostacyclin Drug market has been segmented into
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
By Application, Prostacyclin Drug has been segmented into:
For Injection
For Oral
For Inhalation
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostacyclin Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostacyclin Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostacyclin Drug market.
The report offers in-depth assessment of the growth and other aspects of the Prostacyclin Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Prostacyclin Drug Market Share Analysis
Prostacyclin Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostacyclin Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostacyclin Drug sales, revenue and market share for each player covered in this report.
The major players covered in Prostacyclin Drug are:
United Therapeutics
Teva
Actelion (J & J)
Bayer AG
GSK
Tide Pharma
Toray
Among other players domestic and global, Prostacyclin Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostacyclin Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostacyclin Drug, with price, sales, revenue and global market share of Prostacyclin Drug in 2018 and 2019.
Chapter 3, the Prostacyclin Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostacyclin Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Prostacyclin Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Prostacyclin Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Prostacyclin Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prostacyclin Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Epoprostenol Sodium
1.2.3 Treprostinil
1.2.4 Iloprost
1.2.5 Beraprost Sodium
1.3 Market Analysis by Application
1.3.1 Overview: Global Prostacyclin Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 For Injection
1.3.3 For Oral
1.3.4 For Inhalation
1.4 Overview of Global Prostacyclin Drug Market
1.4.1 Global Prostacyclin Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Prostacyclin Drug Industry Impact
1.6.1 COVID-19 Potential Implications for the Prostacyclin Drug
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Prostacyclin Drug
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 United Therapeutics
2.1.1 United Therapeutics Details
2.1.2 United Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 United Therapeutics SWOT Analysis
2.1.4 United Therapeutics Product and Services
2.1.5 United Therapeutics Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Teva SWOT Analysis
2.2.4 Teva Product and Services
2.2.5 Teva Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Actelion (J & J)
2.3.1 Actelion (J & J) Details
2.3.2 Actelion (J & J) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Actelion (J & J) SWOT Analysis
2.3.4 Actelion (J & J) Product and Services
2.3.5 Actelion (J & J) Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer AG SWOT Analysis
2.4.4 Bayer AG Product and Services
2.4.5 Bayer AG Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GSK SWOT Analysis
2.5.4 GSK Product and Services
2.5.5 GSK Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Tide Pharma
2.6.1 Tide Pharma Details
2.6.2 Tide Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Tide Pharma SWOT Analysis
2.6.4 Tide Pharma Product and Services
2.6.5 Tide Pharma Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Toray
2.7.1 Toray Details
2.7.2 Toray Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Toray SWOT Analysis
2.7.4 Toray Product and Services
2.7.5 Toray Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Prostacyclin Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Prostacyclin Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Prostacyclin Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Prostacyclin Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Prostacyclin Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Prostacyclin Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Prostacyclin Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Prostacyclin Drug Sales and Growth Rate (2015-2020)
4.3 Europe Prostacyclin Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Prostacyclin Drug Sales and Growth Rate (2015-2020)
4.5 South America Prostacyclin Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Prostacyclin Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Prostacyclin Drug Sales, Revenue and Market Share by Country
5.1.1 North America Prostacyclin Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Prostacyclin Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Prostacyclin Drug Sales and Growth Rate (2015-2020)
5.3 Canada Prostacyclin Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Prostacyclin Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Prostacyclin Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Prostacyclin Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Prostacyclin Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Prostacyclin Drug Sales and Growth Rate (2015-2020)
6.3 UK Prostacyclin Drug Sales and Growth Rate (2015-2020)
6.4 France Prostacyclin Drug Sales and Growth Rate (2015-2020)
6.5 Russia Prostacyclin Drug Sales and Growth Rate (2015-2020)
6.6 Italy Prostacyclin Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Prostacyclin Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Prostacyclin Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Prostacyclin Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Prostacyclin Drug Sales and Growth Rate (2015-2020)
7.3 Japan Prostacyclin Drug Sales and Growth Rate (2015-2020)
7.4 Korea Prostacyclin Drug Sales and Growth Rate (2015-2020)
7.5 India Prostacyclin Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Prostacyclin Drug Sales and Growth Rate (2015-2020)
7.7 Australia Prostacyclin Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Prostacyclin Drug Sales, Revenue and Market Share by Country
8.1.1 South America Prostacyclin Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Prostacyclin Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Prostacyclin Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Prostacyclin Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Prostacyclin Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Prostacyclin Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Prostacyclin Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Prostacyclin Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Prostacyclin Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Prostacyclin Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Prostacyclin Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Prostacyclin Drug Sales and Market Share by Type (2015-2020)
10.2 Global Prostacyclin Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Prostacyclin Drug Price by Type (2015-2020)
11 Global Prostacyclin Drug Market Segment by Application
11.1 Global Prostacyclin Drug Sales Market Share by Application (2015-2020)
11.2 Global Prostacyclin Drug Revenue Market Share by Application (2015-2020)
11.3 Global Prostacyclin Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Prostacyclin Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Prostacyclin Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Prostacyclin Drug Market Forecast (2021-2025)
12.2.2 Europe Prostacyclin Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Prostacyclin Drug Market Forecast (2021-2025)
12.2.4 South America Prostacyclin Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Prostacyclin Drug Market Forecast (2021-2025)
12.3 Prostacyclin Drug Market Forecast by Type (2021-2025)
12.3.1 Global Prostacyclin Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Prostacyclin Drug Market Share Forecast by Type (2021-2025)
12.4 Prostacyclin Drug Market Forecast by Application (2021-2025)
12.4.1 Global Prostacyclin Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Prostacyclin Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Prostacyclin Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prostacyclin Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prostacyclin Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Prostacyclin Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. United Therapeutics Basic Information, Manufacturing Base and Competitors
Table 9. United Therapeutics Prostacyclin Drug Major Business
Table 10. United Therapeutics Prostacyclin Drug Total Revenue (USD Million) (2018-2019)
Table 11. United Therapeutics SWOT Analysis
Table 12. United Therapeutics Prostacyclin Drug Product and Services
Table 13. United Therapeutics Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Teva Basic Information, Manufacturing Base and Competitors
Table 15. Teva Prostacyclin Drug Major Business
Table 16. Teva Prostacyclin Drug Total Revenue (USD Million) (2018-2019)
Table 17. Teva SWOT Analysis
Table 18. Teva Prostacyclin Drug Product and Services
Table 19. Teva Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Actelion (J & J) Basic Information, Manufacturing Base and Competitors
Table 21. Actelion (J & J) Prostacyclin Drug Major Business
Table 22. Actelion (J & J) Prostacyclin Drug Total Revenue (USD Million) (2018-2019)
Table 23. Actelion (J & J) SWOT Analysis
Table 24. Actelion (J & J) Prostacyclin Drug Product and Services
Table 25. Actelion (J & J) Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 27. Bayer AG Prostacyclin Drug Major Business
Table 28. Bayer AG Prostacyclin Drug Total Revenue (USD Million) (2018-2019)
Table 29. Bayer AG SWOT Analysis
Table 30. Bayer AG Prostacyclin Drug Product and Services
Table 31. Bayer AG Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. GSK Basic Information, Manufacturing Base and Competitors
Table 33. GSK Prostacyclin Drug Major Business
Table 34. GSK Prostacyclin Drug Total Revenue (USD Million) (2018-2019)
Table 35. GSK SWOT Analysis
Table 36. GSK Prostacyclin Drug Product and Services
Table 37. GSK Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Tide Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Tide Pharma Prostacyclin Drug Major Business
Table 40. Tide Pharma Prostacyclin Drug Total Revenue (USD Million) (2018-2019)
Table 41. Tide Pharma SWOT Analysis
Table 42. Tide Pharma Prostacyclin Drug Product and Services
Table 43. Tide Pharma Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Toray Basic Information, Manufacturing Base and Competitors
Table 45. Toray Prostacyclin Drug Major Business
Table 46. Toray Prostacyclin Drug Total Revenue (USD Million) (2018-2019)
Table 47. Toray SWOT Analysis
Table 48. Toray Prostacyclin Drug Product and Services
Table 49. Toray Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Global Prostacyclin Drug Sales by Manufacturer (2018-2019) (K Units)
Table 51. Global Prostacyclin Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 52. Global Prostacyclin Drug Sales by Regions (2015-2020) (K Units)
Table 53. Global Prostacyclin Drug Sales Market Share by Regions (2015-2020)
Table 54. Global Prostacyclin Drug Revenue by Regions (2015-2020) (USD Million)
Table 55. North America Prostacyclin Drug Sales by Countries (2015-2020) (K Units)
Table 56. North America Prostacyclin Drug Sales Market Share by Countries (2015-2020)
Table 57. North America Prostacyclin Drug Revenue by Countries (2015-2020) (USD Million)
Table 58. North America Prostacyclin Drug Revenue Market Share by Countries (2015-2020)
Table 59. Europe Prostacyclin Drug Sales by Countries (2015-2020) (K Units)
Table 60. Europe Prostacyclin Drug Sales Market Share by Countries (2015-2020)
Table 61. Europe Prostacyclin Drug Revenue by Countries (2015-2020) (USD Million)
Table 62. Asia-Pacific Prostacyclin Drug Sales by Regions (2015-2020) (K Units)
Table 63. Asia-Pacific Prostacyclin Drug Sales Market Share by Regions (2015-2020)
Table 64. Asia-Pacific Prostacyclin Drug Revenue by Regions (2015-2020) (USD Million)
Table 65. South America Prostacyclin Drug Sales by Countries (2015-2020) (K Units)
Table 66. South America Prostacyclin Drug Sales Market Share by Countries (2015-2020)
Table 67. South America Prostacyclin Drug Revenue by Countries (2015-2020) (USD Million)
Table 68. South America Prostacyclin Drug Revenue Market Share by Countries (2015-2020)
Table 69. Middle East & Africa Prostacyclin Drug Sales by Countries (2015-2020) (K Units)
Table 70. Middle East & Africa Prostacyclin Drug Sales Market Share by Countries (2015-2020)
Table 71. Middle East & Africa Prostacyclin Drug Revenue by Countries (2015-2020) (USD Million)
Table 72. Middle East & Africa Prostacyclin Drug Revenue Market Share by Countries (2015-2020)
Table 73. Global Prostacyclin Drug Sales by Type (2015-2020) (K Units)
Table 74. Global Prostacyclin Drug Sales Share by Type (2015-2020)
Table 75. Global Prostacyclin Drug Revenue by Type (2015-2020) (USD Million)
Table 76. Global Prostacyclin Drug Revenue Share by Type (2015-2020)
Table 77. Global Prostacyclin Drug Sales by Application (2015-2020) (K Units)
Table 78. Global Prostacyclin Drug Sales Share by Application (2015-2020)
Table 79. Global Prostacyclin Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 80. Global Prostacyclin Drug Market Share Forecast by Regions (2021-2025)
Table 81. Global Prostacyclin Drug Sales Forecast by Type (2021-2025) (K Units)
Table 82. Global Prostacyclin Drug Market Share Forecast by Type (2021-2025)
Table 83. Global Prostacyclin Drug Sales Forecast by Application (2021-2025)
Table 84. Global Prostacyclin Drug Market Share Forecast by Application (2021-2025)
Table 85. Direct Channel Pros & Cons
Table 86. Indirect Channel Pros & Cons
Table 87. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Prostacyclin Drug Picture
Figure 2. Global Sales Market Share of Prostacyclin Drug by Type in 2019
Figure 3. Epoprostenol Sodium Picture
Figure 4. Treprostinil Picture
Figure 5. Iloprost Picture
Figure 6. Beraprost Sodium Picture
Figure 7. Prostacyclin Drug Sales Market Share by Application in 2018
Figure 8. For Injection Picture
Figure 9. For Oral Picture
Figure 10. For Inhalation Picture
Figure 11. Global Prostacyclin Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Prostacyclin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Prostacyclin Drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Prostacyclin Drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Prostacyclin Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Prostacyclin Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Prostacyclin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Prostacyclin Drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Prostacyclin Drug Revenue Market Share by Regions in 2018
Figure 40. North America Prostacyclin Drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Prostacyclin Drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Prostacyclin Drug Sales and Growth Rate (2015-2020)
Figure 43. South America Prostacyclin Drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Prostacyclin Drug Sales and Growth Rate (2015-2020)
Figure 45. North America Prostacyclin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Prostacyclin Drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Prostacyclin Drug Sales Market Share by Countries in 2018
Figure 48. North America Prostacyclin Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Prostacyclin Drug Revenue Market Share by Countries in 2018
Figure 50. United States Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Prostacyclin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Prostacyclin Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Prostacyclin Drug Revenue Market Share by Countries in 2019
Figure 56. Germany Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Prostacyclin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Prostacyclin Drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Prostacyclin Drug Revenue Market Share by Regions 2019
Figure 64. China Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Prostacyclin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Prostacyclin Drug Sales Market Share by Countries in 2019
Figure 71. South America Prostacyclin Drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Prostacyclin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Prostacyclin Drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Prostacyclin Drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Prostacyclin Drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Prostacyclin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Prostacyclin Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Prostacyclin Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Prostacyclin Drug Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Prostacyclin Drug Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Prostacyclin Drug Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Prostacyclin Drug Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Prostacyclin Drug Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
抗コリン薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Anticholinergic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 急性肝性ポルフィリン症治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Acute Hepatic Porphyria Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- ノイラミニダーゼ阻害薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Neuraminidase Inhibitors Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 新型コロナウイルス感染症薬物APIの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The COVID-19 Drug API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 神経筋遮断薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Neuromuscular Blocking Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…